This review summarizes the findings and importance of 12 articles from research at Columbia University in New York City that were among the most cited in the literature between 2006 and 2011. The 12 articles summarized in this review made important contributions to the field of Alzheimer's disease in the last 5 years. Four of the articles established the Mediterranean diet as a food consumption pattern that may prevent Alzheimer's disease in addition to physical activity. Two of the articles advanced our knowledge of predictors of conversion from mild cognitive impairment to dementia. Four of the articles provided important knowledge of risk factors for the progression of Alzheimer's disease and its complications. Lastly, one of the articles laid the theoretical framework for the study of cognitive reserve, an important modifier of the manifestation of Alzheimer's disease. These studies have advanced our knowledge about risk factors, modifiers, and progression of late onset Alzheimer's disease.
• The Questionable Dementia 1 study (QD1; PI: Devangere Devanand), a cohort study of persons with a diagnosis of mild cognitive impairment (MCI), recruited from a referral memory disorders clinic. The goal of the QD1 study is to identify predictors of progression to dementia among persons with MCI.
Among the 12 most cited articles that resulted from these studies, four reported on modifiable risk factors for AD [1] [2] [3] [4] , one reported on genetic risk factors for AD [10] , two reported on predictors of conversion of MCI to AD [7, 9] , four reported on progression of AD [5, 6, 11, 12] , and one was a review article on an important modifier of AD risk, cognitive reserve [8] . This article is organized following these themes. We provide summaries of each article, put the findings in perspective, and briefly discuss their importance to the field.
STUDIES OF NON-GENETIC RISK FACTORS FOR LATE ONSET ALZHEIMER'S DISEASE
Four of the 12 studies examined the relationship of putative risk factors with incident AD [1] [2] [3] [4] . These studies are summarized in Table 1 . These studies were conducted in WHICAP.
All of the studies examined diet, and more specifically, adherence to the Mediterranean diet, in relation to incident AD or MCI. One of the studies also examined physical activity in addition to diet [4] . One of the studies examined the role of vascular mediation in the relationship of the Mediterranean diet with AD [4] . In summary, these studies found that higher adherence to a Mediterranean diet was related to a lower risk of MCI and AD, that these relationships were not explained by vascular mediation, and were stronger when accompanied with higher physical activity. In relation to the lack of mediation by vascular disease, it is likely that this finding was explained by the lack of sensitivity of medical history and blood markers as surrogates for cerebrovascular disease. We later found that cerebrovascular disease ascertained on brain imaging did suggest a vascular mediation in this relationship [15] .
This compendium of articles is important for several reasons. First, no modifiable risk factors for AD have been identified thus far despite intensive research [16] , and these studies demonstrate that lifestyle factors with available evidence for benefits for cardiovascular disease can also help AD potentially through non-vascular mechanisms. Second, the study of diet and AD had traditionally been limited to the study of specific nutrients (e.g., vitamins) rather than food consumption patterns. Our studies were the first to examine how an established measurable food consumption pattern, the Mediterranean diet, could reduce the risk of AD. Third, one of the studies demonstrated that adhering to two available healthy life-style choices, the Mediterranean diet and physical activity, could jointly decrease the risk of AD. It is important to point out that these studies carefully accounted for confounders such as caloric intake and low education. Thus, we do not believe that these important findings are explained by confounding factors.
STUDIES OF GENETIC RISK FACTORS FOR LATE ONSET ALZHEIMER'S DISEASE
One of the 12 studies examined the relationship of a novel genetic risk factor, SORL1, with AD [10] . Variants in 3′ and 5′ regions of SORL1, the neuronal sorting protein-related receptor, have been found to be associated with late onset familial and sporadic AD in several datasets that were selected for familial aggregation or were ethnically diverse or clinic-based selected series. Our nested case-control study was performed using the community-based WHICAP study. There were 296 patients with probable AD and 428 healthy elderly controls. The participants were of African American (34%), Caribbean Hispanic (51%), or non-Hispanic whites (15%). Several individual single-nucleotide polymorphisms (SNPs) and SNP haplotypes were significantly associated with AD in this prospectively collected community-based cohort, confirming the previously reported positive association of SORL1 with AD. SNP 12 near the 5′ region was associated with AD in African-Americans and Hispanics. Two SNPs in the 3′ region were also associated with AD in African-Americans (SNP 26) and whites (SNP 20) . A single haplotype C-C-A at SNPs 4-6 was associated with AD in Hispanics. However, several different haplotypes were associated with AD in the African-Americans and whites, including the haplotype T-T-C at SNPs 23-25 (p = 0.035) that was significantly associated with AD in the North European whites in a previous report.
The contributions of this article to the field included the confirmation of the association between AD and variants in the SORL1 gene in a population based multiethnic cohort. Also, the discovery of significant association in multiple regions of the gene, and the discovery of different AD-associated haplotypes different from those in other studies revealed that there may be a high degree of allelic heterogeneity, with disease-associated variants occurring on multiple different haplotypic backgrounds. Thus, second attempts to identify the pathogenic variants in SORL1 will likely have to investigate larger regions of the SORL1 gene than simply just between SNPs 8-10 and 22-25. This study is part of a larger effort in genetic epidemiology research in which our group participates that has established SORL-1 as one the most important genetic risk factors for AD [17] [18] [19] [20] [21] after APOE-ε4. Late onset AD is increasing recognized as a complex heterogeneous condition in which multiple pathways and factors are likely to be involved. The discovery of new genetic factors in late onset AD, in this case SORL-1, is providing new insights into these pathways.
STUDIES OF CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE
Two of the 12 articles [7, 9] (Table 2 ) summarized in this review reported neuropsychological and imaging predictors of conversion from non-dementia cognitive impairment to AD in the QD1 study. QD1 was a cohort based in a memory disorders clinic, as compared with the studies of non-genetic and genetic risk factors previously described, which were community-based.
The first article [7] evaluated conversion rates to AD in subtypes of MCI and identified neuropsychological measures most predictive of the time to conversion. This study demonstrated that mildly cognitively impaired patients with memory plus other cognitive domain deficits, rather than those with pure amnestic MCI, constituted the high risk group for conversion. Deficits in verbal memory and psychomotor speed/executive function abilities strongly predicted conversion to AD. This study raised the intriguing possibility that these amnestic "plus" patients constitute a group at high risk for conversion to AD, whereas the pure amnestic MCI patients may not be at such a high risk. However, with longer follow-up, the pure amnestic MCI patients may develop multiple cognitive domain deficits and eventually convert to AD. These findings also suggest that testing for deficits in multiple cognitive domains in addition to those in memory improves the predictive value of neuropsychological testing in patients with MCI. The study showed that combining commonly used neuropsychological tests strongly predicted conversion from MCI to AD, emphasizing the critical role of cognitive testing in evaluation and prediction of outcome in patients with MCI.
The second article [9] evaluated the utility of magnetic resonance imaging (MRI) hippocampal and entorhinal cortex size in predicting conversion from MCI to AD. Hippocampal and entorhinal cortex volumes were each largest in controls, intermediate in MCI non-converters, and smallest in MCI converters to AD. Smaller hippocampal volume and entorhinal cortex volume each predicted time to conversion to AD. Similar results were obtained for hippocampal and entorhinal cortex volume in patients with MCI with MiniMental State Exam (MMSE) scores ≥27/30 (21% converted to AD) and in the subset of patients with amnestic MCI (35% converted to AD). In the total patient sample, when both hippocampal and entorhinal volume were entered into an age-stratified Cox model with gender, MMSE, education, and intracranial volume, smaller hippocampal volume and entorhinal cortex volume predicted time to conversion to AD. Similar results were obtained in a Cox model that also included neuropsychological test scores. Based on logistic regression models in the 3-year follow-up sample, for a fixed specificity of 80%, the addition of hippocampal and entorhinal cortex volumes to demographic and neuropsychological variables markedly improved the sensitivity of a predictive model for conversion to AD to well over 80%.
At the time that these two studies were published, they were the largest studies testing the predictors of conversion from MCI to AD. The study of neuropsychological predictors demonstrated that persons with amnestic MCI and involvement with other cognitive domains represented a higher risk group for conversion than those with pure amnestic MCI. The imaging study demonstrated that hippocampal and entorrinal cortex size add information to the neuropsychological data in predicting conversion from MCI to dementia. The importance of these studies in the field is that it helps clinicians identify persons with MCI at high risk for conversion. This group perhaps should be targeted for interventions.
STUDIES OF PROGRESSION IN ALZHEIMER'S DISEASE
Four of the 12 studies examined the predictors of progression and consequences of AD [6, 11, 12] (Table 3 ). Compared to the previous categories of studies, these studies were conducted in a cohort of persons with AD from Northern Manhattan followed prospectively.
One study examined the association of years of education on AD progression and found that higher years of education were related to steeper cognitive decline [5] . Another study examined the association of vascular risk factors status before AD diagnosis with rate of cognitive decline and found that higher total cholesterol, low-density-lipoprotein cholesterol, and diabetes were associated with faster cognitive decline [6] . One study examined the association of Mediterranean diet adherence before AD diagnosis with mortality among persons with AD [12] and found that persons with higher Mediterranean diet adherence had lower mortality. Lastly, one study found that the incidence of seizures was higher than expected in persons with AD and that younger individuals, African Americans, and those with more severe disease or a focal epileptiform findings on EEG were more likely to have unprovoked seizures [12] .
These studies are important because the prevalence of AD will continue to increase in the absence of established methods for prevention and cure, and because studying disease progression in AD provides insights about its mechanisms. The studies examining the roles of diet and vascular risk factors established that these exposures not only potentially affect the risk of AD but also its course and mortality. The study examining seizures shows clinicians following persons with AD that they should expect the need to treat seizures and provided potential predictors for this complication. The study on education and AD course provides important support for the cognitive reserve hypothesis that is discussed next.
COGNITIVE RESERVE AND ALZHEIMER'S DISEASE
This article was the only one out of the 12 to review a topic in AD [8] suggesting a framework for the study of an important hypothesized modifier of its clinical presentation. Epidemiologic evidence suggests that individuals with higher intelligence quotient, education, occupational attainment, or participation in leisure activities have a reduced risk of developing AD. The concept of cognitive reserve posits that individual differences in how tasks are processed provide differential reserve against brain pathology or age-related changes. This may take two forms, neural reserve and neural compensation. In neural reserve, pre-existing brain networks that are more efficient or have greater capacity may be less susceptible to disruption. In neural compensation, alternate networks may compensate for pathology's disruption of pre-existing networks. Imaging studies have begun to identify the neural substrate of cognitive reserve. Because cognitive reserve may modulate the clinical expression of AD pathology, it is an important consideration in studies of "preclinical" AD and treatment studies. There is also the possibility that directly enhancing cognitive reserve may help forestall the diagnosis of AD.
The AD field is at a juncture in which there is growing acceptance that this disease is more heterogeneous than originally thought and there is uncertainty about the validity of the hypothesis that postulates that brain amyloid deposition is the main culprit. Other aspects such as vascular disease are increasingly recognized as contributors to AD, but even this element has proven insufficient to explain AD risk. In this context, the concept of cognitive reserve has emerged as an important modifier of disease expression that requires further study. Research is needed to better characterize the measurement of this concept and to understand how it affects AD risk. For example, a sensitive measure of cognitive reserve could help the assessment of its modulation of risk factors such as the Mediterranean diet, could improve predictive models for conversion from MCI to AD, and could help better predict to progression of AD.
SUMMARY
The 12 articles summarized in this review made important contributions to the field of AD in the last 5 years. Four of the articles established the Mediterranean diet as a food consumption pattern that may prevent AD in addition to physical activity. Two of the articles advanced our knowledge of predictors of conversion from MCI to dementia. Four of the articles provided important knowledge of risk factors for the progression of AD and its complications. Lastly, one of the articles laid the theoretical framework for the study of cognitive reserve, an important modifier of the manifestation of AD. Summary of most cited articles of predictors of conversion from mild cognitive impairment to Alzheimer's disease. These studies were based in a clinic based cohort of persons with mild cognitive impairment (PI: D. Devanand) in patients with mild cognitive impairment. [7] 148 patients reporting memory problems and 63 group-matched controls.
Patients were followed up semiannually and controls annually Subtypes of MCI were determined by using demographically adjusted regression norms on neuropsychological tests.
Survival analysis was used to identify the most predictive neuropsychological measures.
The outcome was a consensus diagnosis of probable AD At baseline, 108 patients met criteria for amnestic MCI: 87 had memory plus other cognitive domain deficits and 21 had pure memory deficits. The mean duration of follow-up for the 148 patients was 46.6 ± 24.6 months. In 3 years, 32 (50.0%) of 64 amnestic-"plus" and 2 (10.0%) of 20 "pure" amnestic patients converted to AD (p = 0.001). In 148 patients, of 5 a priori predictors, the percent savings from immediate to delayed recall on the SRT and the WAIS-R Digit Symbol were the strongest predictors of time to conversion. From the entire neuropsychological test battery, a stepwise selection procedure retained 2 measures in the final model: total immediate recall on the SRT (OR per 1-point decrease, 1.10; 95% CI, 1.05-1.14; p = 0.0001) and WAIS-R Digit Symbol coding (OR, 1.06; 95% CI, 1.01-1.11; p = 0.01). The combined predictive accuracy of these 2 measures for conversion by 3 years was 86% DP [6] 156 incident AD patients (mean age 83 years at diagnosis) were prospectively followed every 1.5 years
The exposures were vascular factors including medical history (heart disease, stroke, diabetes, hypertension), smoking, and prediagnosis blood lipid measurements (total cholesterol, HDL-C, LDL-C, and triglycerides). The main outcome was change in a composite score of cognitive ability from diagnosis on
In GEE models (adjusted for age, race/ethnicity and education), higher cholesterol (total and LDL-C), and diabetes history were associated with faster cognitive decline. Each 10-unit increase in cholesterol and LDL-C was associated with a 10% of a standard deviation decrease in cognitive score per year of followup (p < 0.001 for total cholesterol, p = 0.001 for LDL-C). HDL and triglycerides were not associated with rate of decline. Diabetes history was associated with an additional 50% of a standard deviation decrease in cognitive score per year (p = 0.05). History of heart disease and stroke were associated with cognitive decline among APOE ε4 carriers only. In a final GEE model that included HDL-C, LDL-C, and diabetes, only higher LDL-C was independently associated with faster cognitive decline AD, Alzheimer's disease; APOE, apolipoprotein E; BMI, body mass index; GEE, general estimating equation; HDL-C, high density lipoproteins; HR, hazards ratio; LDL-C, low density lipoproteins; MeDi, Mediterranean diet; RR, risk ratio.
